probiodrug GmbH, Merck deal

probiodrug granted MRK exclusive worldwide rights to its dipeptidyl peptidase IV (DPP IV) enzyme inhibitors for use in developing therapeutics to treat diabetes and related disorders. DPP IV inhibitor...